Feature | May 02, 2013

Elekta, Philips Research MRI-Guided Radiation Therapy

Dutch clinic joins group dedicated to developing next-generation radiotherapy for treatment of cancer patients

May 2, 2013 — Elekta and Royal Philips Electronics announced that the Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (NKI-AVL, Amsterdam, the Netherlands) has signed an agreement to join a research group to advance the development of an image-guided treatment technology for cancer care. The technology merges radiation therapy and magnetic resonance imaging (MRI) technology in a single system. NKI-AVL is the third member of the research consortium, which will comprise leading radiation oncology centers and clinicians, and already includes the University Medical Center Utrecht (also in the Netherlands) and the University of Texas MD Anderson Cancer Center.

Uniting MRI with a radiation therapy system will provide physicians with exceptional images of a patient's soft tissues and tumor during radiation therapy. This innovation also aims to permit clinicians to adapt treatment delivery in real time for the most precise cancer treatments possible.

"MRI has steadily revolutionized healthcare since its introduction nearly three decades ago, giving clinicians unparalleled views of soft tissues and pathology. Merging this diagnostic capability with the capacity to also treat disease in the same frame of reference could dramatically improve cancer management," says Tomas Puusepp, Elekta president and CEO. "The other consortium members at Elekta, Philips, University Medical Center Utrecht and MD Anderson are delighted that NKI-AVL — an internationally renowned medical center — has joined us in this important effort."

Marcel Verheij, head of the radiotherapy division at NKI-AVL, said, "MRI-guided radiotherapy allows optimal imaging and will therefore improve the accuracy of our treatment delivery. Building on our experience with cone-beam CT-guidance, we are highly motivated to collaborate within the research consortium and contribute to the implementation of MRI-guided adaptive radiotherapy."

"This research exemplifies the essential role that imaging plays in the development of more targeted treatments for cancer," said Gene Saragnese, CEO of imaging systems at Philips Healthcare. "The NKI-AVL has played a crucial role in the software development for CT-guided radiation therapy a decade ago, and this expertise complements the skills that we already possess in this research consortium."

Prior to the establishment of the research consortium, Elekta, Philips and the University Medical Center Utrecht built and tested a prototype system that integrates a linear accelerator and a 1.5T MRI system. The success of these efforts enabled the project to move to the next phase of development and testing by the growing select group of consortium partners.

Radiation therapy and medical imaging already play an essential role in treatment planning, delivery and aftercare, and are proven, cost-effective and safe methods for the treatment of individuals with cancer. Radiotherapy is a critical modality for cancer treatment, either as a frontline treatment or used with other modalities, such as chemotherapy. The procedure involves identifying cancerous tissue and irradiating it with high-energy radiation beams in a way that maximizes sparing of healthy tissues near the tumor. 

The integrated MRI-guided radiation therapy system is in development and not available for sale.

For more information: www.elekta.com

Related Content

Sponsored Content | Videos | Radiation Therapy | January 18, 2019
Join Chris Toth, president of Varian’s Oncology Systems business, for a look at product introductions for 2018 plus
MIM Software Inc. Receives FDA 510(k) Clearance for Molecular Radiotherapy Dosimetry
Technology | Nuclear Imaging | January 16, 2019
MIM Software Inc. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for molecular radiotherapy...
Machine Learning Uncovers New Insights Into Human Brain Through fMRI
News | Neuro Imaging | January 11, 2019
An interdisciplinary research team led by scientists from the National University of Singapore (NUS) has successfully...
Hypertension With Progressive Cerebral Small Vessel Disease Increases Cognitive Impairment Risk
News | Magnetic Resonance Imaging (MRI) | January 08, 2019
Patients with high blood pressure and progression of periventricular white matter hyperintensities showed signs of...
Electronic Brachytherapy Effective in Long-Term Study of 1,000 Early-Stage Breast Cancers
News | Brachytherapy Systems, Women's Healthcare | January 07, 2019
Breast cancer recurrence rates of patients treated with intraoperative radiation therapy (IORT) using the Xoft Axxent...
Brachytherapy Alone Superior Treatment for Intermediate-Risk Prostate Cancer
News | Brachytherapy Systems | January 04, 2019
Patient-reported outcomes (PROs) indicated a significantly different clinician and patient-reported late toxicity...
First Arterial and Venous Atlas of the Human Brain Released
News | Neuro Imaging | January 02, 2019
January 2, 2019 — Imagine an atlas containing an image bank of the blood vessels of the...
MRI Effective for Monitoring Liver Fat in Obese Patients
News | Magnetic Resonance Imaging (MRI) | December 28, 2018
Magnetic resonance imaging (MRI) provides a safe, noninvasive way to monitor liver fat levels in people who undergo...
RayStation 8B Released With Machine Learning Applications for Treatment Planning
Technology | Treatment Planning | December 27, 2018
RaySearch Laboratories released RayStation 8B, the latest version of the radiation therapy treatment planning system (...